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Purpose: The purpose of this study was to examine the influence of acute moderate-intensity exercise on serum
brain-derived neurotrophic factor (BDNF) levels in healthy young Japanese men. BDNF is one of a family of
neurotrophic factors involved in neuronal transmission, modulation and plasticity. Previous human-based studies
have demonstrated that acute exercise leads to increases in BDNF; however, to date there has been no study
conducted among Japanese male subjects.
Methods: Forty young adult Japanese men (aged 24.1 ± 2.9 years) – reduced to a total of thirty three following
subjection to exclusion criteria – performed 30 minutes of exercise at 60% of VO2max on a stationary bicycle. Serum
BDNF was analyzed both before and after exercise.
Results: Eighteen of the total thirty three subjects demonstrated an increase in serum BDNF after exercise.
However, on aggregate, the change in serum BDNF associated with exercise was not significant (p = .17).
Conclusions: This is the first study to demonstrate that serum BDNF levels are not consistently increased by acute
moderate-intensity exercise in Japanese men. It is likely that something in the lifestyle and/or environment of male
Japanese subjects underlies the difference between our findings and studies conducted in other countries.
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Approximately 35.6 million people worldwide were living
with dementia in 2010, with the prevalence expected to in-
crease to 65.7 million in 2030 and 115.4 million in 2050
(Prince et al. 2013). Japan is considered to be one of the
most rapidly aging nations in the world. It is estimated
that the number of Japanese people with dementia will in-
crease from 1.56 million in 2000 to over 3 million by 2025
(Cabinet Office, Government of Japan 2012).
Numerous studies suggest that regular physical activity
could reduce the incidence of cognitive impairment and
dementia in older people at risk for these disorders. For
example, Laurin et al. (2001) demonstrated significantly
lower odds of developing cognitive impairment and
Alzheimer’s disease (AD) in subjects with higher levels of* Correspondence: 12dr02@g.seirei.ac.jp
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in any medium, provided the original work is pphysical activity suggesting that regular physical activity
could represent an important and potent protective factor
against cognitive decline and dementia in elderly persons.
A recent meta-analysis of 29 studies involving aerobic exer-
cise interventions reported modest but significant improve-
ments in attention and processing speed, executive
function and memory in exercise-trained subjects (Smith
et al. 2010). Also, both cross-sectional (Erickson et al. 2009)
and prospective (Erickson et al. 2011) human investigations
suggest that higher aerobic fitness level is associated with
larger hippocampal volume and improved neuronal health.
These reports further suggest that the improvements in
cognitive function associated with aerobic activity may be
mediated by neurophysiological and structural changes in
the brain (Erickson et al. 2009); however, the physiological
mechanisms underlying these effects remain unclear.
One possible mechanism involves changes in brain de-
rived neurotrophic factor (BDNF) levels associated with
aerobic exercise. This relationship was first observed inOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Table 1 Physiological maximal values during graded
exercise test (GXT)
Peak value
VO2max (mL/min/kg) 37.2 (6.5)
Work rate (W) 190.4 (29.1)
HR (bpm) 173.7 (13.5)
RER 1.29 (0.14)
Borg Scale 17.9 (1.8)
Values shown are means (±SD). [N = 40].
VO2max maximal oxygen consumption, HR heart rate, RER respiratory
exchange ratio.
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increases the expression of BDNF in the rat brain (Neeper
et al. 1995). Since this discovery, a number of studies have
sought to establish the link between the neurothrophin
BDNF and post-exercise enhancement of mood and cog-
nitive functions in humans (Zoladz and Pilc 2010). BDNF
is an important molecular mediator of structural and func-
tional plasticity in the brain and plays many important
roles in nervous system function, including neuroplasti-
city, neuronal growth, repair and differentiation. Altered
BDNF levels have been described in several neurological
and psychiatric disorders including AD (Schindowski et al.
2008), Huntington’s disease (Ciammola et al. 2007), major
depression (Laske et al. 2007) and schizophrenia (Reis
et al. 2008). Furthermore, higher BDNF serum levels are
associated with a slower rate of cognitive decline in AD
patients (Laske et al. 2011).
Several studies in human subjects have demonstrated
that acute aerobic exercise induced increased BDNF in per-
ipheral blood (Nofuji et al. 2012; Schmolesky et al. 2013;
Gustafsson et al. 2009; Rasmussen et al. 2009; Ferris et al.
2007; Gold et al. 2003; Rojas Vega et al. 2006; Tang et al.
2008). The acute effect of exercise on human serum BDNF
levels is characterized as a transient, moderate (approxi-
mately 20 to 40%) increase (Gold et al. 2003; Rojas Vega
et al. 2006; Tang et al. 2008). Serum BDNF levels rise dur-
ing aerobic exercise, and quickly return to baseline levels
upon exercise cessation, approximately 10–15 minutes
after exercise termination (Rojas Vega et al. 2006; Tang
et al. 2008). Ferris et al. (2007) suggested that low intensity
exercise was insufficient to elevate BDNF levels relative to
baseline, while high intensity exercise for a comparable
duration significantly elevated serum BDNF levels.
While many studies in this field have been done in
Western subject, there was a single study in Japanese sub-
ject (Nofuji et al. 2012). Nofuji et al. (2012) demonstrated
an effect of acute aerobic exercise on peripheral blood
BDNF levels in Japanese women. However, there has been
no study to date that has investigated the effects of acute
aerobic exercise on peripheral blood BDNF levels in
Japanese men. Therefore, the aim of this study was to clarify
the effect of acute physical activity on the circulating BDNF
responses in Japanese men. In the present study, we
measured the serum BDNF concentrations before and after
aerobic exercise healthy young Japanese men subjects.Results
GXT
The mean peak values of work rate (190.43 ± 29.06 W),
VO2max (37.19 ± 6.47 mL/min/kg), HR (173.73 ± 13.45 bpm),
RER (1.29 ± 0.14), and Borg Scale (17.85 ± 1.78), during
graded exercise test are presented in Table 1. These data are
consistent with the ACSM criteria for estimating VO2max.Endurance ride measures
On the basis of the exclusion criteria, 7 subjects were ex-
cluded from the analysis (2 subjects with an over-load and
5 subjects with an under-load). An analysis was performed
on 33 remaining subjects. The average of the physiological
values collected during exercise (3 minutes rest, 3 minutes
warm-up, and each 5 minutes average during 30 minutes
of endurance ride) are shown in Table 2. These results
suggest that exercise intensity was maintained at a moder-
ate level during the endurance ride.
Serum BDNF responses
Basal BDNF values, post-exercise BDNF values, pre-post
change in serum BDNF (⊿BDNF) and pre-post percent-
age change in serum BDNF (%⊿BDNF) are presented in
Table 3. 18 of 33 subjects demonstrated increased serum
BDNF after exercise compared with their personal base-
line. However, on average for the entire group, post-
exercise serum BDNF values did not increase relative to
the baseline average (p = 0.168). There is a positive correl-
ation between basal BDNF value and post-exercise BDNF
value (r = .475, p < 0.01). There are no significant differ-
ences between the group with increased BDNF and the
one with decreased BDNF in baseline values (Table 4).
Equally, there are no significant correlations between
exercise-induced BDNF change and basal baseline values
(Table 5).
Discussion
This is the first study to examine changes in serum BDNF
levels associated with a single bout of aerobic exercise in
healthy young Japanese men. Based upon previous re-
search in non-Japanese populations, we hypothesized that
moderate aerobic exercise would lead to significantly in-
creased serum BDNF levels in Japanese male subjects.
However, serum BDNF increase due to exercise was evi-
dent in only half of the subjects, and group mean values of
serum BDNF were not significantly increased by exercise
compared with the pre-exercise group mean. The study
found that serum BDNF did not increase consistently in
healthy young Japanese men exposed to 30 minutes of
moderate exercise.
Table 2 Change physiological values during the endurance rides
Rest Warm-up Ex1-5 Ex6-10 Ex11-15 Ex16-20 Ex21-25 Ex26-30
VO2 (mL/min/kg) 7.1 (2.4) 12.9 (2.1) 18.3 (2.7) 21.4 (3.2) 21.8 (3.5) 21.8 (3.5) 21.8 (3.6) 21.8 (3.5)
%VO2max (%) 20.4 (7.0) 36.0 (4.9) 51.3 (6.0) 59.5 (4.1) 60.6 (3.5) 60.5 (3.5) 60.4 (3.2) 60.4 (3.4)
W/kg - 0.99 (0.17) 1.4 (0.21) 1.53 (0.27) 1.51 (0.28) 1.47 (0.29) 1.45 (0.28) 1.43 (0.27)
HR (bpm) 75.4 (11.3) 111.0 (12.3) 132.7 (15.1) 145.9 (13.8) 151.5 (14.1) 154.2 (13.4) 156.1 (13.8) 157.8 (12.8)
%HRR (%)a - 32.3 (8.2) 52.1 (11.4) 64.0 (10.9) 69.1 (11.5) 71.6 (10.8) 73.3 (11.1) 74.8 (10.3)
RER 0.8 (0.07) 0.88 (0.08) 1.06 (0.11) 1.05 (0.1) 1.03 (0.11) 1.01 (0.11) 1.0 (0.09) 0.99 (0.09)
Borg scale - 8.1 (1.8) 11.4 (2.5) 13.2 (2.2) 14.1 (2.1) 14.8 (2.1) 15.2 (2.0) 15.5 (2.2)
Values shown are means (±SD). [N = 33].
VO2 oxygen consumption, VO2max maximal oxygen consumption, HR heart rate, HRR heart rate reserve, RER respiratory exchange ratio.
a(HR – rest HR)/(220 – age – rest HR) *100.






[N = 18] [N = 15]
Basal BDNF (ng/ml) 14.2 (4.7) 15.8 (5.4) 0.40
Age (years) 23.2 (1.7) 24.8 (3.1) 0.11
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onstrated that brief periods of moderate aerobic exercise
are associated with transient increases of serum BDNF
concentrations (Goekint et al. 2008; Gold et al. 2003;
Gustafsson et al. 2009); however, a study by Castellano
and White (2008) suggested a negative relationship
between moderate aerobic exercise and serum BDNF.
Nofuji et al. (2012) reported that healthy young Japanese
women subjects did not display increased serum BDNF
levels after moderate exercise. The results of the present
study prove that healthy young Japanese male subjects did
not exhibit increased serum BDNF levels. Moderate aerobic
exercise therefore does not seem to affect serum BDNF
levels in healthy young Japanese populations as a whole.
Basal BDNF values from other studies have been re-
ported as 24.95 ± 7.28 ng/ml (Schmolesky et al. 2013) and
22.94 ± 9.12 ng/mL (Cho et al. 2012) in healthy young
men. Nofuji et al. (2008) demonstrated basal BDNF levels
of 23.63 ± 2.94 ng/ml in sedentary young Japanese men.
Among participants in this study, baseline BDNF was
14.9 ± 5.0 ng/ml. Although slightly lower than the values
reported in prior studies, this level can be considered to
be within the normal range (1.5 to 30.9 ng/mL) for basal
BDNF in healthy subjects (Knaepen et al. 2010).
One factor that might be associated with our findings is
the possible effect of stress hormones. Schmolesky et al.
(2013) showed that BDNF levels may actually decrease in
sedentary control subjects (by approximately 13% on aver-
age), and suggested this may be due to stress related to the
laboratory environment and/or blood collection. Thus, itTable 3 BDNF values and change
Mean (SD) Max value Minimal value
Basal BDNF 14.9 (5.0) 26.1 3.2
Post-exercise BDNF 15.9 (5.6) 25.7 4.8
⊿BDNFa 1.0 (4.2) 10.57 −6
%⊿BDNFb 15 (59.9) 295.3 −45.6
[N = 33].
apost BDNF value - basal BDNF value.
b(post BDNF value - basal BDNF value)/basal BDNF value.is possible that an exercise induced increase in BDNF
may be offset by a stress-induced decrease associated
with the blood collection process. Other studies have
shown that elevated stress, exogenous cortisol applica-
tion, or glucocorticoid receptor agonism can lead to re-
duced BDNF levels (Pluchino et al. 2013). If stress levels
are particularly high or individual stress reactions are
particularly strong, they could obscure the impact of ex-
ercise on the BDNF level.
One other possible explanation for our findings is the ef-
fect of human BDNF gene polymorphism (Val66Met),
which is more common among Japanese individuals than
those of Western heritage. Shimizu et al. (2004) showed
that there are significant differences between individuals
from Japan (50.3%), Italy (43.2%) and the USA (27.1%) in
genotype frequencies of BDNF 196G/A (Val66Met) poly-
morphism, with the prevalence being significantly higher
in the Japanese population (p < 0.0001). Val66Met is known
to impair intracellular trafficking and neuronal activity-
dependent secretion of BDNF (Egan et al. 2003). It is
thought that Val66Met polymorphism carriers demonstrate
lower BDNF production during exercise compared withHeight (cm) 171.5 (6.4) 168.5 (7.8) 0.25
Weight (kg) 64.6 (10.8) 61.6 (8.6) 0.40
BMI 21.9 (2.8) 21.6 (2.1) 0.78
VO2max (ml/min/kg) 35.1 (5.6) 37.5 (7.6) 0.30
Peak value of GXT (W/kg) 2.9 (0.3) 3.16 (0.7) 0.20
Resting HR (bpm) 74.5 (9.9) 76.6 (13.2) 0.61
HR durind endurance
exercise (bpm)
150.6 (15.3) 148.4 (10.2) 0.65
Values shown are mean (±SD). [N = 33].
VO2max maximal oxygen consumption, BMI body mass index, HR heart rate.
Table 5 The results of a correlation analysis between
basal characteristics and BDNF change
⊿BDNF %⊿BDNF
r p value r p value
Age (years) −0.25 0.15 −0.15 0.40
Height (cm) −0.11 0.54 −0.14 0.41
Weight (kg) 0.00 0.99 −0.18 0.30
BMI −0.05 0.77 −0.19 0.28
VO2max (ml/min/kg) −0.06 0.72 0.06 0.74
Peak value of work rate (W/kg) −0.02 0.92 0.08 0.65
Resting HR (bpm) −0.13 0.45 −0.18 0.30
[N = 33].
VO2max maximal oxygen consumption, BMI body mass index, Resting HR
resting heart rate.
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the Japanese population, the prevalence of BDNF poly-
morphism is reported to be approximately 50% (Itoh et al.
2004; Itoh et al. 2005). Interestingly, this prevalence is ap-
proximately equal to the proportion of subjects demon-
strating increased serum BDNF after exercise in the
present study.
Although serum levels of BDNF can be affected by BDNF
production in peripheral cells or endocrine organs, includ-
ing vascular endothelial cells (Nakahashi et al. 2000), im-
mune cells (e.g. T and B lymphocytes) (Besser and Wank
1999; Kerschensteiner et al. 1999) and submandibular
glands (Tsukinoki et al. 2007; Tsukinoki et al. 2006), the
brain is considered to be the major contributor to exercise-
related increases in circulating BDNF. Rasmussen et al.
(2009) reported that the brain contributes almost 75% of all
BDNF in circulation under normal circumstances, and that
the brain generally demonstrates a significant increase in
BDNF production during prolonged exercise (a 2- to 3-fold
increase of the production at rest). The BDNF polymorph-
ism found in half of the Japanese population affects intra-
cellular trafficking of BDNF, reducing neuronal activity-
dependent BDNF release by approximately 25% (Chen
et al. 2008; Egan et al. 2003). While we were unable to dir-
ectly measure the BDNF polymorphism for each individual
participant, we believe there is a possibility that the preva-
lence of BDNF polymorphism among Japanese individuals
might account for our finding that, on average, BDNF levels
do not increase after exercise.
Limitations of this study include the absence of control
groups (both a rest control group and one consisting of
subjects of Western heritage) or a vigorous exercise sub-
group to explore possible dose–response relationships
between exertion-level and BDNF levels, as well as the
lack of measurements of gene polymorphism (Val66Met)
among our Japanese male subjects. Further studies are
needed to explain changes in serum BDNF levelsassociated with exercise, as well as to elucidate the effect
of BDNF polymorphism on exercise-induced BDNF secre-
tion in Japanese subjects. Future studies should ascertain
BDNF polymorphism status for each study participant,
and included in analyses of the relationship between exer-
cise and serum BDNF levels. Also, the influence of differ-
ent levels of exercise intensity, its duration and type
should be compared across sexes, age groups, health con-
ditions, and fitness levels in order for exercise-induced
BDNF secretion among Japanese individuals to be fully
understood.
In conclusion, an exposure to 30 minutes of moderate
aerobic exercise was not found to be associated with a
consistent increase in serum BDNF concentrations in
healthy young Japanese men. It is likely that something in
the lifestyle and/or environment of male Japanese subjects
underlies the difference between our findings and studies
conducted in other countries.
Methods
Subjects and study design
The study population consisted of 40 healthy young
Japanese men (mean age 24.1 ± 2.9 year; mean height
170.6 ± 6.7 cm; mean weight 64.8 ±9.4 kg; mean BMI
22.2 ±2.4 kg/m2; mean ± SE) with a sedentary lifestyle,
which was defined as not having engaged in 30 minutes
or more of purposeful physical activity per day at least
three times a week over the previous 6 months. All sub-
jects denied the presence of cardiopulmonary, meta-
bolic, and musculoskeletal disease. All experiments
were conducted in accordance with the Declaration of
Helsinki and approved by the institutional review board of
Seirei Christopher University, Japan. Written informed con-
sent was also obtained from all participants.Study protocol
The study was conducted in two phases. In the first phase,
each subject performed a graded exercise test (GXT) on a
stationary bicycle to determine the work load that corre-
sponded to 60% maximal oxygen consumption (VO2max)
for that individual. This level of exertion was chosen be-
cause previous studies on subjects from Western popula-
tions used this intensity (Castellano and White 2008; Gold
et al. 2003; Schulz et al. 2004). During the second phase,
blood samples were collected from the subjects immedi-
ately before and after 30 minute endurance rides with a
fixed exercise intensity level of 60% VO2max. There was a
rest period of 48 hours between the GXT and the endur-
ance ride. Participants were instructed to forgo strenuous
exercise for 24 hours prior to both the baseline VO2max
measurement and the 30 minute endurance ride. Similarly,
food, caffeine, alcohol intake and smoking were prohibited
during the 3 hours prior to each phase.
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Baseline VO2max was evaluated using a cycle ergometer on
which participants exercised to volitional fatigue. Cardio-
pulmonary and metabolic parameters, maximal work
rate, VO2max, and respiratory exchange ratio (RER) were
determined on a breath-by-breath basis with samples
averaged for 5-second intervals using the Aero Monitor
AE-310 s (Minato Ika, Japan). Heart rate (HR) and rhythm
were monitored during the GXT via electrocardiography
(Bedside monitor scope 1; Nihon Kohden, Japan). We
used the American College of Sports Medicine (ACSM)
criteria for reaching VO2max, in which a participant meets
at least two of the following criteria: (1) a leveling off of
the VO2; (2) a rate of perceived exertion >17, using Borg’s
scale; (3) volitional exhaustion; and (4) achievement of the
participant’s age-predicted maximal heart rate [calculated
from (220 – age)]. We defined the VO2max plateau as a
VO2 change < 2 mL kg − 1 min − 1 over the last 60 seconds
of the test.
Endurance ride
After a 3 minutes’ warm-up period at a power of 50 w, each
subject performed 30 minutes of exercise at a power output
that corresponded to 60% of his VO2max, as determined
using the GXT. The power output was adjusted in incre-
ments of 2 w to reach 60% of VO2max ± 100 mL/min/kg, as
needed. Metabolic, ventilator, and heart rate parameters
were collected at 1-minute intervals during the rides.
Blood sampling and analysis
Basal and post-exercise BDNF levels were examined by
drawing a 5-mL blood sample from the antecubital vein,
with the subject in a sitting position, into a vacuum
blood collection tube containing blood separating
agent (NP-SP1029, NIPRO, Osaka, Japan), and using 21
gauge needles. The blood was sampled within 5 minutes
before exercise initiation and 3 minutes post-exercise. It
was clotted at room temperature for one hour and then
centrifuged (Tabletop Centrifuge 2040, Kubota, Tokyo,
Japan) at 3000 g for 15 minutes and the supernatant was
decanted and stored in a −20°C freezer until analysis
(approximately 2 to 3 months). Serum BDNF levels
were determined using a commercially available quan-
titative sandwich enzyme-linked immunosorbent assay
(ELISA) kit, in accordance with protocols provided by the
test manufacturer (R& D Systems, USA). Each sample was
tested twice with a sensitivity threshold of 20 pg/mL,
producing an intra-assay variance under 6.2%, which
was within the range specified by the manufacturer.
Exclusion criteria
An analysis was conducted excluding subjects with a lon-
ger than 5 minutes’ period of deviation from the appropri-
ate load strength (outside the range of 50-70% of VO2maxat average value for each minute) during the 30 minutes
endurance ride.
Statistical analysis
Paired t-tests were used to compare serum BDNF levels
measured prior to exercise onset, with BDNF levels mea-
sured after completion of the endurance rides. The statis-
tical significance level was set at p < 0.05, and data were
presented as mean ± standard deviation (SD). All statistical
analyses were conducted using the software package (IBM
SPSS Statistics 19 for Windows, Chicago, IL).
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